Amgen Inc. Peo Actually Paid Comp Amt
Amgen Inc. (AMGN) reported Peo Actually Paid Comp Amt of $49.38 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-07.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-07
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $49.38M DEF 14A · filed 2026-04-07 |
| 2024-12-31 | $12.66M DEF 14A · filed 2026-04-07 |
| 2023-12-31 | $29.11M DEF 14A · filed 2026-04-07 |
| 2022-12-31 | $41.66M DEF 14A · filed 2026-04-07 |
| 2021-12-31 | $17.04M DEF 14A · filed 2026-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |